Insider: Flowers Lee SVP of Business Development - HCW Biologics Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 5,720 | 0 | 5,720 |
| Value | $23,280.40 | $0.00 | $23,280.40 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 05/08/2025 | AAP | 962 | Direct | COM | $26.00 | $25,012.00 | 5,720 |
| 06/08/2023 | AAP | 10,000 | Direct | COM | $2.16 | $21,574.00 | 111,308 |
| 08/23/2021 | AAP | 5,605 | Direct | COM | $3.95 | $22,156.57 | 91,667 |
| 08/20/2021 | AAP | 7,853 | Direct | COM | $4.08 | $32,069.30 | 86,062 |
| 08/19/2021 | AAP | 10,532 | Direct | COM | $4.25 | $44,785.22 | 78,209 |
| 07/22/2021 | AAP | 31,250 | Direct | COM | $8.00 | $250,000.00 | 67,677 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research